Cotización Teleflex - TFX

Herramientas de nivel profesional para inversores individuales.

Premium

Último Precio

193.98

Postura de Compra

Postura de Venta

Volume Operado de la Acción

0.00 Rango del Día 0.00

193.49 Rango de 52 semanas 257.85

Capitalización de Mercado [m]

9.009B

Precio Anterior

193.98

Precio de Apertura

Hora

Última hora de negociación

Volumen financiero

Precio Promedio Ponderado

Volumen promedio (3 m)

353,253

Acciones en circulación

46,443,734

Rendimiento del Dividendo

0.70%

Ratio Precio/Utilidad

25.28

Beneficio por acción (BPA)

7.67

turnover

2.98B

Beneficio neto

356.33M

Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (25% of 2021 sales), interventional (15%), anesthesia (14%), surgical (13%), interve... Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (25% of 2021 sales), interventional (15%), anesthesia (14%), surgical (13%), interventional urology (12%), original-equipment manufacturing (9%), and all other (12%). Geographic exposure for the business is primarily in the U.S., which accounts for 60% of revenue, with international markets making up the remainder. Mostrar más

Sector

Surgical,med Instr,apparatus

Industria

Surgical,med Instr,apparatus

Sitio web

www.teleflex.com

Sede

Wilmington, Delaware, USA

Fundado

Teleflex Inc is listed in the Surgical,med Instr,apparatus sector of the New York Stock Exchange with ticker TFX. The last closing price for Teleflex was US$193.98. Over the last year, Teleflex shares have traded in a share price range of US$ 193.49 to US$ 257.85.

Teleflex currently has 46,443,734 shares in issue. The market capitalisation of Teleflex is US$9.01 billion. Teleflex has a price to earnings ratio (PE ratio) of 25.28.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Teleflex to Present at the Jefferies London Healthcare Conference

WAYNE, Pa., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Jefferies London Healthcare Conference, on...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Teleflex Announces Quarterly Dividend

WAYNE, Pa., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per...

Teleflex Reports Third Quarter Financial Results and Full Year 2024 Outlook

WAYNE, Pa., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the third quarter ended September 29, 2024. Third quarter...

First Patient Enrolled in Teleflex’s Barrigel™ Rectal Spacer Trial for Post Radical Prostatectomy Radiation Therapy (PPRT)

WAYNE, Pa., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the first patient enrolled in the latest...

Teleflex launches next-generation Arrow™ VPS Rhythm™ DLX Device and NaviCurve™ Stylet in Canada

WAYNE, Pa., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the launch of two new devices in Canada...

New Data Presented at ASTRO 2024 Further Demonstrate the Safety and Efficacy of Barrigel™ Rectal Spacer, the First and Only Sculptable Hyaluronic Acid Rectal Spacer, in Patients Undergoing Radiation Therapy for Prostate Cancer(1-3)

• Barrigel™ rectal spacer provides high quality rectal spacing, enabling low dose to the rectum during prostate cancer radiation therapy, with an excellent toxicity and safety profile; and low...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	-8.55	-4.22159680047	202.53	203.33	193.49	511095	196.39897545	CS
4	-41.43	-17.5990824519	235.41	241.41	193.49	495366	211.85385923	CS
12	-45.68	-19.0603354753	239.66	249.905	193.49	353253	227.75162152	CS
26	-14.94	-7.1510626077	208.92	249.905	193.49	436597	221.23775462	CS
52	-13.9	-6.68654993265	207.88	257.85	193.49	361337	223.29567209	CS
156	-146.01	-42.9453807465	339.99	356.72	177.633	356527	245.57116289	CS
260	-144.44	-42.6806926305	338.42	449.375	177.633	314704	285.53894057	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
AAMAA Mission Acquisition Corp	US$ 10.05 (0.00%)	0
AACT.UAres Acquisition Corporation II	US$ 10.96 (0.00%)	0
AACTAres Acquisition Corporation II	US$ 10.88 (0.00%)	0
AAAlcoa Corporation	US$ 40.59 (0.00%)	0
AAgilent Technologies	US$ 134.28 (0.00%)	0
AAMAA Mission Acquisition Corp	US$ 10.05 (0.00%)	0
AACT.UAres Acquisition Corporation II	US$ 10.96 (0.00%)	0
AACTAres Acquisition Corporation II	US$ 10.88 (0.00%)	0
AAAlcoa Corporation	US$ 40.59 (0.00%)	0
AAgilent Technologies	US$ 134.28 (0.00%)	0
AAMAA Mission Acquisition Corp	US$ 10.05 (0.00%)	0
AACT.UAres Acquisition Corporation II	US$ 10.96 (0.00%)	0
AACTAres Acquisition Corporation II	US$ 10.88 (0.00%)	0
AAAlcoa Corporation	US$ 40.59 (0.00%)	0
AAgilent Technologies	US$ 134.28 (0.00%)	0